SonoThera
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Haskins Way South, South San Francis...Phone Number
(415) 376-7840Website
www.sonothera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About SonoThera
SonoThera is a privately held biotechnology company focused on developing a next-generation approach to genetic medicine using ultrasound-mediated, non-viral gene delivery. The company is working to address one of the major limitations in current gene therapy: the safe and efficient delivery of genetic material into specific tissues in the human body without relying on viral vectors. Traditional gene therapies often use engineered viruses to transport DNA or RNA into cells, but these methods can face challenges such as immune responses, limited cargo capacity, and manufacturing complexity. SonoThera is developing a platform that instead uses focused ultrasound energy combined with specially designed therapeutic constructs to temporarily increase cell membrane permeability, enabling genetic material to enter targeted tissues in a controlled and repeatable manner.Explore more
SonoThera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SonoThera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if SonoThera had a recent Job posting/layoffs
Earning: See what the market has to say on SonoThera recently announced quarterly report
SonoThera, which may be a good buyer, showed buying intent in Masked Content Topic
Check if SonoThera has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when SonoThera launches new products
Check out if SonoThera is spiking on competitors!
Funding: Get notified immidiatlly once SonoThera has new funding data
Congratulate Masked Content for being promoted to Masked Content at SonoThera
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to SonoThera
Compare insights from companies similar to SonoThera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SonoThera is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SonoThera is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SonoThera.
SonoThera financials insights
Gather financial insights about SonoThera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$60.8M
2026
Series B
$125M
SonoThera Tech Stack
A closer look at the technologies used by SonoThera
Most Recent Scoops
Open Position
Open Position
Open Position
Hiring Plans
SonoThera has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
SonoThera News & Media
SonoThera Closes Oversubscribed $125M Series B
SAN FRANCISCO, CA, SonoThera, a biotechnology company developing next-generation genetic medicines to address the root causes of disease, announced the closing of an oversubscribed $125 million Series B.Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
With a suite of big-name backers and tech built on FDA-approved components, SonoThera is set to revolutionize genetic medicine.SonoThera Launches With $125M Series B
SOUTH SAN FRANCISCO, CA, SonoThera™ today announced it will officially launch a $125 million Series B funding round.SonoThera Presents New Data at the 2025 MDA Conference Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery (UMD) in Treating Duchenne Muscular Dystrophy
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DMD--SonoTheraâ„¢, a biotechnology company dedicated to treating the root cause of human diseases through developing the next generation of genetic medicines, today announced it will present new data at the annual Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held March 16-19th in Dallas, Texas. The preclinical data highlights the ability of ultrasound-mediated delivery (UMD) to express nonviral genetic constructs in a
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding SonoThera
Sign Up For FreeTo access detailed company insights
SonoThera is a privately held biotechnology company focused on developing a next-generation approach to genetic medicine using ultrasound-mediated, non-viral gene delivery. The company is working to address one of the major limitations in current gene therapy: the safe and efficient delivery of genetic material into specific tissues in the human bo... Read More
